Velto is a GLP-1 medication and health tracker for patients on Ozempic, Wegovy, and similar treatments, available on iOS.
Product velocity
Intense
Daily rank 🇺🇸
—
Health & Fitness
Sentiment
5.0
1 reviews
Nemesis
Glucose Buddy Diabetes Tracker
The App DNA
What makes this app unique?
Users hire Velto to manage complex, non-standard treatment schedules that standard 7-day trackers fail to support.
For Patients prescribed GLP-1 medications like Ozempic or Wegovy who need to manage complex, non-standard treatment schedules and track side effects.
Key features
Allows configuration of medication schedules between 3 and 30 days instead of a fixed 7-day cycle.
Exports medication and treatment history to CSV format for external review or doctor consultation.
Tracks both oral GLP-1 pills and injectable medications within a single interface.
How much does it cost?
Freemium model gates data portability behind a premium tier, targeting users who need clinical-grade reporting for doctor visits.
Velocity
Intense developmentShow more...
5 versions in history. Development pace: intense.
Who built it?
MoneyCoach UG
13+ apps tracked · Health & Fitness
MoneyCoach: Budget Planner
Particular Augmented Reality
IBAN Calculator by MoneyCoach
Expense Tracker Money Spaces
Riku
4Ever Relationship Coach
Sandflow - Screen Time Control
World Emergency SOS Numbers
Benji · Quit Habits Tracker
Beibi Healthy BLW Baby Recipes
Feat: Microbiome Meal Plan
AutoBuddy-Vehicle Fuel Consumption Cost CalculatorUser Sentiment
What do users think recently?
Fresh user feedback skews thrilled. Users appreciate the medication tracking interface simplifies the daily management of complex injection schedules for patients.
How are ratings & reviews evolving?
What users say, by theme
- The medication tracking interface simplifies the daily management of complex injection schedules for patients
1 of 1 recent reviews analyzed · limited sample
Read the full review analysisCompetition
Competitive landscape for Velto GLP-1 Tracker
How's the Health & Fitness market?
Velto currently holds a #71 Grossing position in its category on the iOS App Store, though it experienced a 39-spot drop this week. The volatility suggests the app struggles to maintain consistent chart visibility against established health-tracking incumbents.
Read the market outlookThe rivals identified
By Azumio Inc.
This app serves the same core medical tracking intent as Velto but with a significantly larger, established user base in the diabetes management space.
- Integrates directly with blood glucose monitors to automate data entry for diabetic users
- Provides comprehensive A1c tracking and long-term trend analysis for chronic condition management
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Velto GLP-1 Tracker
Where is it heading?
The GLP-1 tracking category is consolidating around apps that offer both medication and nutritional logging, putting pressure on standalone trackers. Velto's ability to retain users depends on moving beyond manual entry to automated health data synthesis, or it risks being absorbed by larger calorie-counting platforms.
- The latest release added weekly and monthly review stories, indicating active feature investment rather than maintenance mode.
- Grossing rank volatility (39-spot drop) signals that the current retention loop is insufficient to hold chart position against established incumbents.
The SWOT
- Custom interval scheduling functions as a defensible barrier against rigid, 7-day-locked competitors.
- Multi-medication support broadens the addressable user base beyond injection-only patients.
- Education partnerships with clinics could serve as a B2B distribution channel for clinical-grade tracking.
Next best moves
Audit CSV export usage because it is the primary premium gate → increase conversion rate
The counter-intuitive read
The app's limited review volume is a strategic advantage…
Read the full takeFeature gaps
Barcode scanner for food logging (available in Lose It! but missing here) +1
Since the last report: Velto pivoted to a freemium pricing model and repositioned its core scheduling features as primary differentiators.
Bottom line
Velto succeeds by solving the specific pain point of non-standard GLP-1 scheduling, but its reliance on manual logging leaves it vulnerable to automated trackers, so the PM should prioritize clinical-grade integrations to defend the premium tier.
Unlock 2 critical frictions, 1 market threat and the analyst’s take.
Access the full report for freeSources
Report last updated